tiprankstipranks
The Fly

Tarsus Pharmaceuticals 2.809M share Spot Secondary priced at $44.50

Tarsus Pharmaceuticals 2.809M share Spot Secondary priced at $44.50

The deal size was increased to $125M in common stock from $100M in common stock. Goldman Sachs, BofA, Barclays and Oppenheimer acted as joint book running managers for the offering.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Questions or Comments about the article? Write to editor@tipranks.com